Pregnancy and fetal outcomes after exposure to mefloquine in the pre-and periconception period and during pregnancy

Clinical Infectious Diseases

Volumn 54, Issue 11, 2012, Pages

  Schlagenhauf, Patricia ^a   Blumentals, William A ^b   Suter, Pia ^b   Regep, Loredana ^b   Vital Durand, Gabriel ^b   Schaerer, Martin T ^b   Boutros, Margarita Suarez ^b   Rhein, Hans Georg ^b   Adamcova, Miriam ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MEFLOQUINE;

ADULT; ARTICLE; BIRTH DEFECT; CHEMOPROPHYLAXIS; CONGENITAL MALFORMATION; DATA BASE; DELIVERY; DRUG SAFETY; FETUS; FETUS DEATH; FETUS WASTAGE; HUMAN; INDUCED ABORTION; INFANT; MAJOR CLINICAL STUDY; MALARIA; MATERNAL SMOKING; OUTCOMES RESEARCH; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TOXOPLASMOSIS; TREATMENT DURATION;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTIMALARIALS; CHEMOPREVENTION; FEMALE; HUMANS; INFANT, NEWBORN; MALARIA; MEFLOQUINE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; YOUNG ADULT;

EID: 84861038509     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis215     Document Type: Article

References (32)

1. World Tourism Organisation. Available at: http://unwto.org/. Accessed 27 February 2012.
2. Rogerson S. Malaria in pregnancy and the newborn. Adv Exp Med Biol 2010; 659:139-52.
3. Newman RD, Parise ME, Stutsker L, Nahlen B, Steketee RW. Safety, efficacy and determinants of the effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plas-modium falciparum endemic sub-Saharan Africa. Trop Med Internat Health 2003; 8:488-506.
4. Lindsay S, Ansell J, Selman C, Cox V, Hamilton K, Walraven G. Effect of pregnancy on exposure to malaria mosquitoes. Lancet 2000; 355:1972.
5. Subramanian D, Moise K, White A. Imported malaria in pregnancy. Report of four cases and review of management. Clin Infect Dis 1992; 15:408-13.
6. Dolan G, ter Kuile FO, Jacoutot V. Bed nets for the prevention of malaria and anaemia in pregnancy. Trans R Soc Trop Med Hyg 1993; 87:620-6.
7. Lengeler C. Insecticide treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev 2004 (2):CD000363.
8. McGready R, Hamilton KA, Simpson JA. Safety of the insect repellent N, N-diethyl-m-toluamide (DEET) in pregnancy. Am J Trop Med Hyg 2001; 65:285-9.
9. Croft AM. Malaria prevention in travellers. Clin Evid 2004: 1125-49.
10. Wolfe MS, Cordero JF. Safety of chloroquine in chemosuppres-sion of malaria during pregnancy. Br Med J (Clin Res Ed) 1985; 290:1466-7.
11. Briggs G, Freeman R, Yaffe S. A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
12. Hellgren U, Rombo L. Alternatives for malaria chemoprophylaxis during the first trimester of pregnancy: our personal view. J Travel Med 2010; 17:130-2.
13. Ward SA, Sevene EJ, Hastings IM, Nosten F, McGready R. Anti-malarial drugs and pregnancy: safety, pharmacokinetics and phar-macovigilance. Lancet Infect Dis 2007; 7:136-44.
14. Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG. The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J 2010; 9:357.
15. March of Dimes Birth Defects Foundation. Fact sheets: birth defects, miscarriage and stillbirth; leading categories of birth defects; and perinatal profiles: statistics for monitoring state maternal and infant health. 2001. Available at: www.healthfinder.gov/orgs/hr0255.htm. Accessed 27 February 2012.
16. Food and Drug Administration. Reviewer guidance. Evaluating the risk of drug exposure in human pregnancies. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration, 2005.
17. Schardein JL. Chemically induced birth defects. 3rd ed. New York: Marcel Dekker Inc, 2000.
18. Holmes LB. Human teratogens: update 2010. Birth Defects Res A Clin Mol Teratol 2011; 91:1-7.
19. EUROCAT. EUROCAT final activity report to European Commission March 2004 to August 2007. EUROCAT Central Registry. Coleraine, UK: University of Ulster, 2008.
20. Congenital malformations worldwide-a report from the international clearinghouse for birth defects monitoring systems. Non-governmental organisation of the World Health Organisation. Amsterdam: Elsevier, 1991.
21. Metropolitan Atlanta congenital defect program (MACDP, 1999-2003), 2007.
22. Bar-Oz B, Moretti ME, Mareels G, Tittelboom T, Koren G. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999; 354:1700-1.
23. Vanhauwere B, Maradit H, Kerr L. Postmarketing surveillance of prophylactic mefloquine (Lariam®) use in pregnancy. Am J Trop Med Hyg 1998; 58:17-21.
24. Nybo Andersen AM, Wohlfart J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register study. BMJ 2000; 320:1708-12.
25. Nosten F, McGready R, d'Alessandro U, et al. Antimalarial drugs in pregnancy: a review. Curr Drug Saf 2006; 1:1-15.
26. Nosten F, ter-Kuile K, Maelankiri L, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994; 169:595-603.
27. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Am J Trop Med Hyg 1996; 55:50-6.
28. Steketee RW, Wirima JJ, Hightower AW, et al. The effect of malaria and malaria prevention on offspring birth-weight, prematurity and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg 1996; 55:33-41.
29. Nosten F, Karbwang J, White NJ, Honeymoon, Na BangChang K, Bunnag D, Harinasuta T. Mefloquine anti-malarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Br J Clin Pharmacol 1990; 30:79-85.
30. Phillips-Howard PA, Steffen R, Kerr L, et al. Safety of mefloquine and other anti-malarial agents in the first trimester of pregnancy. J Travel Med 1998; 5:121-6.
31. Balocco R, Bonati M. Mefloquine prophylaxis against malaria for female travellers of childbearing age. Lancet 1992; 340: 309-10.
32. Smoak BL, Writer JV, Keep LW, Cowan J, Chantelois JL. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army service women. J Infect Dis 1997; 176:831-3.